1. Home
  2. SCM vs SLDB Comparison

SCM vs SLDB Comparison

Compare SCM & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

HOLD

Current Price

$12.30

Market Cap

397.8M

Sector

Finance

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$6.54

Market Cap

444.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCM
SLDB
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.8M
444.9M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
SCM
SLDB
Price
$12.30
$6.54
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$13.00
$14.70
AVG Volume (30 Days)
171.7K
999.5K
Earning Date
03-03-2026
03-05-2026
Dividend Yield
11.10%
N/A
EPS Growth
N/A
N/A
EPS
1.09
N/A
Revenue
$102,538,895.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.19
$2.41
52 Week High
$15.56
$7.37

Technical Indicators

Market Signals
Indicator
SCM
SLDB
Relative Strength Index (RSI) 36.96 60.93
Support Level $12.10 $6.29
Resistance Level $13.11 $6.63
Average True Range (ATR) 0.31 0.36
MACD -0.11 0.03
Stochastic Oscillator 11.72 76.33

Price Performance

Historical Comparison
SCM
SLDB

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: